Transaction DateRecipientSharesTypePriceValue
25th October 2019Raymond F Schinazi7,906Open or private purchase$1.15$9,091.90
24th October 2019Raymond F Schinazi5,094Open or private purchase$1.15$5,858.10
23rd October 2019Raymond F Schinazi3,935Open or private purchase$1.04$4,086.89
1st April 2019Raymond F Schinazi36,946Conversion of derivative$13.60$502,465.60
1st April 2019Raymond F Schinazi56,102Conversion of derivative$0.00
Cocrystal Pharma
Cocrystal Pharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Cocrystal Pharma, Inc. is a biotechnology company. It focuses on the discovery and development of novel antiviral therapeutics. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.

Ticker: COCP
Sector: Health Technology
Industry: Pharmaceuticals: Generic
SEC Central Index Key (CIK): 1412486
Employees: 11
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags